Huang-Ping Yu Selected Research

Flutamide (Eulexin)

2/2007	Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway.
2/2006	Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-{beta}-dependent HO-1.
1/2006	Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1.
12/2005	PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage.
7/2005	Mechanism responsible for the salutary effects of flutamide on cardiac performance after trauma-hemorrhagic shock: Upregulation of cardiomyocyte estrogen receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huang-Ping Yu Research Topics

Disease

49	Wounds and Injuries (Trauma) 01/2017 - 07/2005
47	Hemorrhage 01/2016 - 07/2005
15	Hemorrhagic Shock 01/2017 - 07/2005
12	Lung Injury 01/2020 - 05/2006
12	Shock 12/2015 - 02/2006
12	Body Weight (Weight, Body) 07/2012 - 02/2006
7	Pneumonia (Pneumonitis) 01/2021 - 12/2008
7	Neoplasms (Cancer) 01/2021 - 06/2003
4	Acute Lung Injury 06/2020 - 02/2015
4	Edema (Dropsy) 02/2015 - 10/2009
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 02/2015
3	Inflammation (Inflammations) 01/2022 - 03/2018
3	Bacteremia 02/2021 - 01/2016
3	Infections 01/2021 - 06/2016
3	Ischemia 01/2019 - 06/2011
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2015
2	Hyperplasia 01/2019 - 01/2019
2	Necrosis 01/2019 - 01/2016
2	Lung Diseases (Lung Disease) 03/2018 - 02/2015
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2016
2	Alcoholic Hepatitis 01/2017 - 06/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 12/2015
2	Pain (Aches) 01/2015 - 01/2015
2	Postoperative Pain 01/2015 - 01/2015
2	Sepsis (Septicemia) 10/2008 - 02/2006
1	Chemical and Drug Induced Liver Injury 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021

Drug/Important Bio-Agent (IBA)

23	Peroxidase (Myeloperoxidase)IBA 01/2017 - 02/2006
22	CytokinesIBA 02/2021 - 08/2006
22	Interleukin-6 (Interleukin 6)IBA 01/2017 - 05/2006
19	Estrogen ReceptorsIBA 08/2012 - 07/2005
17	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017 - 09/2006
11	Proteins (Proteins, Gene)FDA Link 06/2014 - 05/2006
10	ResveratrolIBA 01/2021 - 09/2008
10	salicylhydroxamic acid (SHAM)IBA 07/2012 - 02/2006
9	Estrogens (Estrogen)FDA Link 01/2013 - 12/2005
8	Chemotactic FactorsIBA 06/2011 - 09/2006
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2007
7	chromium mesoporphyrinIBA 01/2012 - 02/2006
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 09/2008
6	Alanine Transaminase (SGPT)IBA 01/2017 - 09/2008
6	WortmanninIBA 07/2012 - 06/2007
5	Superoxides (Superoxide)IBA 01/2021 - 10/2009
5	LipopolysaccharidesIBA 06/2020 - 02/2015
5	NAD (NADH)IBA 04/2010 - 05/2006
5	Fulvestrant (Faslodex)FDA Link 04/2010 - 02/2006
5	Flutamide (Eulexin)FDA LinkGeneric 02/2007 - 07/2005
5	Estrogen Receptor betaIBA 09/2006 - 01/2006
4	Immunosuppressive Agents (Immunosuppressants)IBA 04/2021 - 06/2016
4	p38 Mitogen-Activated Protein KinasesIBA 01/2013 - 03/2011
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2009 - 01/2006
4	Estradiol (Delestrogen)FDA LinkGeneric 06/2007 - 03/2006
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021 - 01/2016
3	Tropisetron (Navoban)IBA 01/2016 - 01/2012
3	Androgen Receptor AntagonistsIBA 05/2015 - 07/2005
3	sirtinolIBA 02/2015 - 06/2009
3	3,3',4,5'-tetrahydroxystilbeneIBA 08/2012 - 01/2011
3	Aspartic Acid (Aspartate)FDA Link 01/2012 - 07/2010
3	Transaminases (Aminotransferases)IBA 01/2012 - 07/2010
3	Alanine (L-Alanine)FDA Link 01/2012 - 07/2010
3	Messenger RNA (mRNA)IBA 04/2010 - 05/2006
3	Interleukin-10 (Interleukin 10)IBA 06/2009 - 01/2007
3	Ringer's LactateIBA 07/2008 - 07/2005
3	estradiol-bovine serum albuminIBA 03/2008 - 04/2007
3	NF-kappa B (NF-kB)IBA 09/2007 - 06/2007
3	Estrogen Receptor alphaIBA 09/2007 - 08/2006
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2021 - 01/2017
2	Phosphodiesterase 4 InhibitorsIBA 01/2020 - 03/2018
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2018 - 12/2015
2	Pharmaceutical PreparationsIBA 11/2017 - 01/2017
2	Maraviroc FDA Link 01/2016 - 01/2013
2	osthol (osthole)IBA 12/2015 - 01/2013
2	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2015 - 07/2010
2	Malondialdehyde (Propanedial)IBA 01/2014 - 06/2011
2	Propofol (Diprivan)FDA LinkGeneric 05/2013 - 02/2006
2	PPAR gammaIBA 01/2013 - 03/2009
2	Cell Adhesion MoleculesIBA 06/2011 - 09/2006
2	Heme Oxygenase-1IBA 05/2011 - 09/2006
2	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2010 - 02/2006
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 06/2009 - 02/2006
2	NitritesIBA 06/2007 - 05/2006
2	NitratesIBA 06/2007 - 05/2006
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2007 - 06/2007
2	Androgen Receptors (Androgen Receptor)IBA 12/2005 - 07/2005
1	dihydroguaiaretic acidIBA 01/2022
1	Free RadicalsIBA 01/2022
1	LipidsIBA 02/2021

Therapy/Procedure

34	Resuscitation 01/2017 - 12/2005
9	Liver Transplantation 04/2021 - 12/2015
7	Therapeutics 04/2021 - 12/2015
4	Length of Stay 01/2021 - 01/2016
4	Laparotomy 07/2008 - 07/2005
3	Organ Transplantation 11/2017 - 06/2016
2	Cholecystectomy 01/2021 - 01/2017
2	Injections 01/2020 - 01/2017
2	Transurethral Resection of Prostate (TURP) 01/2019 - 01/2019